Myasthenia gravis represents chronic autoimmune condition that primarily affects the neuromuscular junction. This junction mediates the transfer of signals from nerves to muscles, enabling movement. In myasthenia gravis, the body's immune system erroneously attacks these receptors, resulting weakness and fatigue in the motor units. The indications